Review of rabeprazole in the treatment of gastro-oesophageal reflux disease.

about

A review of rabeprazole in the treatment of acid-related diseases Prospective, observational study using rabeprazole in 455 patients with laryngopharyngeal reflux disease.Rabeprazole: a pharmacologic and clinical review for acid-related disorders

P2860

Q36661321-A2EBE6F5-2138-4B44-B367-072C829572CE Q51518486-D1BA8A49-C26D-47CD-911C-43FBC8204F6A Q56431955-2D771364-2F63-4A1E-8489-F4EDD1DFC8EE

P2860

Review of rabeprazole in the treatment of gastro-oesophageal reflux disease.

Item

http://www.wikidata.org/entity/Q35609697

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Review of rabeprazole in the treatment of gastro-oesophageal reflux disease.

@ast

Review of rabeprazole in the treatment of gastro-oesophageal reflux disease.

@en

type

Item

label

Review of rabeprazole in the treatment of gastro-oesophageal reflux disease.

@ast

Review of rabeprazole in the treatment of gastro-oesophageal reflux disease.

@en

prefLabel

Review of rabeprazole in the treatment of gastro-oesophageal reflux disease.

@ast

Review of rabeprazole in the treatment of gastro-oesophageal reflux disease.

@en

P1476

Review of rabeprazole in the treatment of gastro-oesophageal reflux disease.

@en

P2093

Bjarni Thjodleifsson

http://www.w3.org/2001/XMLSchema#string

P2860

The pharmacology of the gastric acid pump: the H+,K+ ATPase

Long-term results of a prospective randomized comparison of total fundic wrap (Nissen-Rossetti) or semifundoplication (Toupet) for gastro-oesophageal reflux.

Importance of pH control in the management of GERD.

Review article: the control of gastric acid and Helicobacter pylori eradication.

Symptomatic gastro-oesophageal reflux, abnormal oesophageal acid exposure, and mucosal acid sensitivity are three separate, though related, aspects of gastro-oesophageal reflux disease

Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial.

A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease.

Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive oesophagitis.

Rabeprazole, 20 mg once daily or 10 mg twice daily, is equivalent to omeprazole, 20 mg once daily, in the healing of erosive gastrooesophageal reflux disease.

Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group.

P304

137-149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1517/14656566.5.1.137

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14680443

http://www.w3.org/2001/XMLSchema#string

Review of rabeprazole in the treatment of gastro-oesophageal reflux disease.

about

P2860

P2860

Review of rabeprazole in the treatment of gastro-oesophageal reflux disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698